vs
GE医疗（CCRN）与Forestar Group Inc.（FOR）财务数据对比。点击上方公司名可切换其他公司
Forestar Group Inc.的季度营收约是GE医疗的1.2倍（$273.0M vs $236.8M），Forestar Group Inc.净利率更高（5.6% vs -35.0%，领先40.7%），Forestar Group Inc.同比增速更快（9.0% vs -23.6%），GE医疗自由现金流更多（$16.1M vs $-157.1M），过去两年Forestar Group Inc.的营收复合增速更高（-9.6% vs -21.0%）
GE医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，品牌标识为GE HealthCare。公司主要业务分为四大板块：包含分子影像、CT、磁共振、妇科筛查及X光设备的医学影像业务、超声业务，以及聚焦远程患者监测、麻醉呼吸护理、心脏诊断、婴幼儿护理的患者护理解决方案业务，此外还开展医药相关业务。
福雷斯特集团是一家住宅地块开发企业，总部位于得克萨斯州阿灵顿，业务覆盖美国21个州的51个市场。截至2020年12月31日的12个月内，该公司交付了11518块住宅地块，目前在纽约证券交易所上市，自2002年起就是美国规模最大的住宅建筑商D.R. Horton的控股子公司。
CCRN vs FOR — 直观对比
营收规模更大
FOR
是对方的1.2倍
$236.8M
营收增速更快
FOR
高出32.6%
-23.6%
净利率更高
FOR
高出40.7%
-35.0%
自由现金流更多
CCRN
多$173.2M
$-157.1M
两年增速更快
FOR
近两年复合增速
-21.0%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $236.8M | $273.0M |
| 净利润 | $-82.9M | $15.4M |
| 毛利率 | — | 20.1% |
| 营业利润率 | -30.2% | 7.6% |
| 净利率 | -35.0% | 5.6% |
| 营收同比 | -23.6% | 9.0% |
| 净利润同比 | -2109.7% | -6.7% |
| 每股收益（稀释后） | $-2.56 | $0.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCRNFOR
| Q4 25 | $236.8M | $273.0M | ||
| Q3 25 | $250.1M | $670.5M | ||
| Q2 25 | $274.1M | $390.5M | ||
| Q1 25 | $293.4M | $351.0M | ||
| Q4 24 | $309.9M | $250.4M | ||
| Q3 24 | $315.1M | $551.3M | ||
| Q2 24 | $339.8M | $318.4M | ||
| Q1 24 | $379.2M | $333.8M |
净利润CCRNFOR
| Q4 25 | $-82.9M | $15.4M | ||
| Q3 25 | $-4.8M | $86.9M | ||
| Q2 25 | $-6.7M | $32.9M | ||
| Q1 25 | $-490.0K | $31.6M | ||
| Q4 24 | $-3.8M | $16.5M | ||
| Q3 24 | $2.6M | $81.5M | ||
| Q2 24 | $-16.1M | $38.7M | ||
| Q1 24 | $2.7M | $45.0M |
毛利率CCRNFOR
| Q4 25 | — | 20.1% | ||
| Q3 25 | 20.4% | 22.3% | ||
| Q2 25 | 20.4% | 20.4% | ||
| Q1 25 | 20.0% | 22.6% | ||
| Q4 24 | — | 22.0% | ||
| Q3 24 | 20.4% | 23.9% | ||
| Q2 24 | 20.8% | 22.5% | ||
| Q1 24 | 20.4% | 24.9% |
营业利润率CCRNFOR
| Q4 25 | -30.2% | 7.6% | ||
| Q3 25 | -2.4% | 16.9% | ||
| Q2 25 | -2.1% | 11.2% | ||
| Q1 25 | -0.3% | 11.6% | ||
| Q4 24 | -1.1% | 8.7% | ||
| Q3 24 | 0.9% | 19.7% | ||
| Q2 24 | -5.7% | 16.2% | ||
| Q1 24 | 0.8% | 17.6% |
净利率CCRNFOR
| Q4 25 | -35.0% | 5.6% | ||
| Q3 25 | -1.9% | 13.0% | ||
| Q2 25 | -2.4% | 8.4% | ||
| Q1 25 | -0.2% | 9.0% | ||
| Q4 24 | -1.2% | 6.6% | ||
| Q3 24 | 0.8% | 14.8% | ||
| Q2 24 | -4.7% | 12.2% | ||
| Q1 24 | 0.7% | 13.5% |
每股收益（稀释后）CCRNFOR
| Q4 25 | $-2.56 | $0.30 | ||
| Q3 25 | $-0.15 | $1.70 | ||
| Q2 25 | $-0.20 | $0.65 | ||
| Q1 25 | $-0.02 | $0.62 | ||
| Q4 24 | $-0.13 | $0.32 | ||
| Q3 24 | $0.08 | $1.59 | ||
| Q2 24 | $-0.47 | $0.76 | ||
| Q1 24 | $0.08 | $0.89 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $108.7M | $211.7M |
| 总债务越低越好 | — | $793.2M |
| 股东权益账面价值 | $322.8M | $1.8B |
| 总资产 | $449.0M | $3.2B |
| 负债/权益比越低杠杆越低 | — | 0.44× |
8季度趋势，按日历期对齐
现金及短期投资CCRNFOR
| Q4 25 | $108.7M | $211.7M | ||
| Q3 25 | $99.1M | $379.2M | ||
| Q2 25 | $81.2M | $189.2M | ||
| Q1 25 | $80.7M | $174.3M | ||
| Q4 24 | $81.6M | $132.0M | ||
| Q3 24 | $64.0M | $481.2M | ||
| Q2 24 | $69.6M | $359.2M | ||
| Q1 24 | $5.2M | $416.2M |
总债务CCRNFOR
| Q4 25 | — | $793.2M | ||
| Q3 25 | — | $802.7M | ||
| Q2 25 | — | $872.8M | ||
| Q1 25 | — | $872.5M | ||
| Q4 24 | — | $806.8M | ||
| Q3 24 | — | $706.4M | ||
| Q2 24 | — | $706.1M | ||
| Q1 24 | — | $705.7M |
股东权益CCRNFOR
| Q4 25 | $322.8M | $1.8B | ||
| Q3 25 | $408.1M | $1.8B | ||
| Q2 25 | $412.2M | $1.7B | ||
| Q1 25 | $418.2M | $1.6B | ||
| Q4 24 | $419.0M | $1.6B | ||
| Q3 24 | $424.7M | $1.6B | ||
| Q2 24 | $433.3M | $1.5B | ||
| Q1 24 | $462.4M | $1.5B |
总资产CCRNFOR
| Q4 25 | $449.0M | $3.2B | ||
| Q3 25 | $538.2M | $3.1B | ||
| Q2 25 | $553.8M | $3.1B | ||
| Q1 25 | $576.2M | $3.0B | ||
| Q4 24 | $589.3M | $3.0B | ||
| Q3 24 | $597.4M | $2.8B | ||
| Q2 24 | $602.9M | $2.7B | ||
| Q1 24 | $648.4M | $2.6B |
负债/权益比CCRNFOR
| Q4 25 | — | 0.44× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.52× | ||
| Q1 25 | — | 0.53× | ||
| Q4 24 | — | 0.50× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.47× | ||
| Q1 24 | — | 0.48× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.2M | $-157.0M |
| 自由现金流经营现金流 - 资本支出 | $16.1M | $-157.1M |
| 自由现金流率自由现金流/营收 | 6.8% | -57.5% |
| 资本支出强度资本支出/营收 | 0.9% | 0.0% |
| 现金转化率经营现金流/净利润 | — | -10.19× |
| 过去12个月自由现金流最近4个季度 | $40.1M | $93.0M |
8季度趋势，按日历期对齐
经营现金流CCRNFOR
| Q4 25 | $18.2M | $-157.0M | ||
| Q3 25 | $20.1M | $256.3M | ||
| Q2 25 | $4.2M | $15.8M | ||
| Q1 25 | $5.7M | $-19.8M | ||
| Q4 24 | $24.2M | $-450.0M | ||
| Q3 24 | $7.5M | $119.2M | ||
| Q2 24 | $82.4M | $-61.7M | ||
| Q1 24 | $6.0M | $-59.2M |
自由现金流CCRNFOR
| Q4 25 | $16.1M | $-157.1M | ||
| Q3 25 | $17.9M | $255.6M | ||
| Q2 25 | $2.3M | $15.0M | ||
| Q1 25 | $3.8M | $-20.5M | ||
| Q4 24 | $21.7M | — | ||
| Q3 24 | $6.3M | $118.4M | ||
| Q2 24 | $79.6M | $-62.3M | ||
| Q1 24 | $3.8M | $-59.8M |
自由现金流率CCRNFOR
| Q4 25 | 6.8% | -57.5% | ||
| Q3 25 | 7.2% | 38.1% | ||
| Q2 25 | 0.8% | 3.8% | ||
| Q1 25 | 1.3% | -5.8% | ||
| Q4 24 | 7.0% | — | ||
| Q3 24 | 2.0% | 21.5% | ||
| Q2 24 | 23.4% | -19.6% | ||
| Q1 24 | 1.0% | -17.9% |
资本支出强度CCRNFOR
| Q4 25 | 0.9% | 0.0% | ||
| Q3 25 | 0.9% | 0.1% | ||
| Q2 25 | 0.7% | 0.2% | ||
| Q1 25 | 0.6% | 0.2% | ||
| Q4 24 | 0.8% | 0.0% | ||
| Q3 24 | 0.4% | 0.1% | ||
| Q2 24 | 0.8% | 0.2% | ||
| Q1 24 | 0.6% | 0.2% |
现金转化率CCRNFOR
| Q4 25 | — | -10.19× | ||
| Q3 25 | — | 2.95× | ||
| Q2 25 | — | 0.48× | ||
| Q1 25 | — | -0.63× | ||
| Q4 24 | — | -27.27× | ||
| Q3 24 | 2.92× | 1.46× | ||
| Q2 24 | — | -1.59× | ||
| Q1 24 | 2.23× | -1.32× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
FOR
| D.R.Horton Inc. | $183.8M | 67% |
| Other | $89.2M | 33% |
